drugset / Trial / NCT01861613
Seroprevalence of Hepatitis B and Immune Response to Hepatitis B Vaccination in Chinese College Students
Phase 4
Completed
2040 enrolled
Hui Zhuang
Guangxi Center for Disease Control and Prevention · collab
NaSingle-groupOpen-labelPrevention
Summary
At present, children less than 15 y of age have been regarded as a key group for hepatitis B immunization in China. However, there is not yet special immunization strategy for population above 15 y of age. In this study, we investigated the seroprevalence of hepatitis B and immune response to HB vaccine among Chinese college students to uncover the need on universal mass vaccination or booster immunization only for students with HBV vaccination history against hepatitis B in Chinese college students to inform decision making.
Timeline
- Start
- 2009-09
- Primary completion
- 2011-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Engerix-B | Vaccine | 20 ug/ml | — |